Successful Erlotinib Treatment for a Patient with Gefitinib-Related Hepatotoxicity and Lung Adenocarcinoma Refractory to Intermittently Administered Gefitinib

A 73-year-old Japanese man was histologically diagnosed with lung adenocarcinoma harboring an exon 19 deletion in the epidermal growth factor receptor. The patient was treated with gefitinib for 6 weeks until he developed substantially elevated hepatic enzyme levels that resulted in the discontinuat...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Tatsuya Nagano, Yoshikazu Kotani, Kazuyuki Kobayashi, Masahiro Katsurada, Yukihisa Hatakeyama, Suya Hori, Daisuke Tamura, Daisuke Kasai, Yasuhiro Funada, Yoshihiro Nishimura
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Wiley 2011-01-01
סדרה:	Case Reports in Pulmonology
גישה מקוונת:	http://dx.doi.org/10.1155/2011/812972
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!